Investing.com - Financial Markets Worldwide
🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

Miners, Ashtead support UK shares; AstraZeneca gains

Published 18/06/2019, 08:29
Miners, Ashtead support UK shares; AstraZeneca gains
AZN
-
GSK
-
AHT
-
FTMC
-
FTNMX551030
-

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)
* FTSE 100 up 0.1%, FTSE 250 down 0.2%
* AstraZeneca biggest boost to FTSE 100
* Ashtead rises after annual results
* Focus shifting to Fed policy meeting

June 18 (Reuters) - London's FTSE 100 edged higher on
Tuesday with tool hire firm Ashtead gaining after an upbeat
earnings report and miners boosted by a rise in copper prices
driven by expectations of a global shortfall in production.
The miner-heavy main index was up 0.1% while the FTSE 250
midcap index .FTMC lost 0.2% by 0708 GMT.
Ashtead AHT.L rose nearly 3%, topping the FTSE 100
leader-board, while miners .FTNMX1770 were up 1% as a key mine
in Chile halved output due to a strike. Drugmaker AstraZeneca AZN.L was the biggest boost to the
FTSE 100 with a 1.1% rise after its cancer medicine Lynparza was
approved as a first-line maintenance treatment for a type of
advanced ovarian cancer by the European Commission. Rival
GlaxoSmithKline GSK.L also climbed.
Market focus is gradually shifting to a two-day meeting of
the U.S. Federal Reserve, with market pricing showing investors
expect Wednesday's policy statement to open the way to a cut in
interest rates by the central bank next month.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.